Five finalists have been shortlisted to win up to $80 000 for ventures that can deliver positive social impact for some of Africa’s most marginalised people. The finalists run projects in areas ranging from early childhood development to medical technology and renewable energy. They come from Kenya, Lesotho, South Africa and Zimbabwe.

Every year, sepsis kills over 3.5 million people in Africa alone. Sepsis happens when the body’s immune system overreacts to an infection. In many cases it is preventable if diagnosed early enough. Hutano aims to change this outlook by improving the tools for diagnosis, particularly in low-resource settings and developing countries, through an innovative way of testing for sepsis.
If a person has sepsis, the likelihood of death increases by 7.6% for every hour that passes without the patient being treated with antibiotics. Early diagnosis is therefore absolutely critical. In low resource settings, sepsis diagnosis is done through simple measurements such as such as temperature, heart rate and breathing rate. This can be misleading and result in inappropriate treatment. The laboratory test for sepsis can take up to 24 hours (resulting in a loss of valuable time), and it is prone to false negatives.
Hutano Diagnostics is developing a ground-breaking lateral flow device (LFD) for the identification of children with a fever that will develop sepsis. This test works in combination with a smart phone app to bring this solution into the patient’s hands. A child with a fever has their blood added to the test after a finger prick, and 15 minutes later the parent, community health worker, or nurse knows if the child needs antibiotics or not, as well as if the fever will progress to a severe outcome.
This lowers the risk to the child, allows for earlier interventions, and reduces the cost and complications due to sepsis, freeing up resources for those who need them the most. The test is simple enough to be used by untrained members of the public, while being sophisticated and accurate enough to be of high value to trained clinical professionals in a variety of settings.







